000 01279 a2200349 4500
005 20250513151649.0
264 0 _c19981110
008 199811s 0 0 eng d
022 _a0361-090X
024 7 _a10.1046/j.1525-1500.1998.00055.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIakoubov, L Z
245 0 0 _aNucleosome-releasing treatment makes surviving tumor cells better targets for nucleosome-specific anticancer antibodies.
_h[electronic resource]
260 _bCancer detection and prevention
_c1998
300 _a470-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntibodies, Antinuclear
_xpharmacology
650 0 4 _aAntibodies, Monoclonal
_xpharmacology
650 0 4 _aAntineoplastic Agents, Phytogenic
_xpharmacology
650 0 4 _aApoptosis
650 0 4 _aChromatin
_xmetabolism
650 0 4 _aDexamethasone
_xpharmacology
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aNucleosomes
_xdrug effects
650 0 4 _aTumor Cells, Cultured
650 0 4 _aVincristine
_xpharmacology
700 1 _aTorchilin, V P
773 0 _tCancer detection and prevention
_gvol. 22
_gno. 5
_gp. 470-5
856 4 0 _uhttps://doi.org/10.1046/j.1525-1500.1998.00055.x
_zAvailable from publisher's website
999 _c9692822
_d9692822